FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

PMA: P130010 · Supplement: S005 · Decision Jan 15, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
Trade Name
VEGA Steroid-Eluting Endocardial Leads (VEGA™ R45, VEGA™ R52, and VEGA™ R58)
PMA Number
P130010
Supplement Number
S005
Device Class
FDA Class 3
Product Code
NVN
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
January 15, 2026
Date Received
December 16, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

manufacturing process improvements for welding of pacing leads

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NVN Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes